EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ESCO2 inhibition induces cell cycle arrest and apoptosis in breast cancer via the P53-CDK1 axis and the BAX/Bcl2/caspase signaling cascade

Pingchuan Li, Lineng Wei, Meng Li, Xiaoqiang Liu, Huawei Yang

Frontiers in Oncology · 10.07.2025 · 15

DOI: 10.3389/fonc.2025.1585945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 10.07.2025. Verfasst von Pingchuan Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Key Laboratory of Breast Cancer Diagnosis and Treatment Research of Guangxi Department of Education, Guangxi Medical Un…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is a major threat to women’s health, and dysregulation of the cell cycle is a critical driver of its progression. ESCO2, a potential key regulator of the cell cycle, is implicated in cancer development; however, its specific role and mechanisms in breast cancer remain poorly understood.

Methods

We analyzed differentially expressed genes between breast cancer and normal breast samples from GEO datasets to identify potential key regulators of the cell cycle pathway. ESCO2 expression was further investigated in breast cancer cell lines. Functional assays, including overexpression and knockdown of ESCO2 in MDA-MB-231 and MDA-MB-468 cells, were performed to assess its effects on the cell cycle and apoptosis. Molecular mechanisms were explored using Western blot, and rescue experiments were conducted to validate key regulatory pathways.

Results

Analysis of the GSE38959 and GSE70947 datasets identified 541 common differentially expressed genes, with 26 genes enriched in the cell cycle pathway. ESCO2 interacted with multiple cell cycle-related genes and was significantly overexpressed in breast cancer. Overexpression of ESCO2 promoted DNA replication, while its knockdown induced G2/M phase arrest via the ESCO2-P53-CDK1 regulatory axis, and triggered apoptosis through the BAX/Bcl2/caspase9/caspase7 signaling cascade. The effects of ESCO2 knockdown on the cell cycle and apoptosis were rescued by siP53.

Conclusion

Our findings reveal that ESCO2 is upregulated in breast cancer and may contribute to cell cycle regulation and apoptosis through the p53-CDK1 and BAX/Bcl-2-caspase pathways. These results highlight ESCO2 as a potential therapeutic target and provide new mechanistic insights into breast cancer progression.

Schlagwörter

Stichwörter der Autor:innen

ESCO2apoptosisbreast cancercell cyclep53

Autor:innen und Institutionen

  • Department of Breast Surgery, Key Laboratory of Breast Cancer Diagnosis and Treatment Research of Guangxi Department of Education, Guangxi Medical University Cancer Hospital, Nanning, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, P., Wei, L., Li, M., Liu, X., & Yang, H. (2025). ESCO2 inhibition induces cell cycle arrest and apoptosis in breast cancer via the P53-CDK1 axis and the BAX/Bcl2/caspase signaling cascade. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1585945

Vancouver

Li P, Wei L, Li M, Liu X, Yang H. ESCO2 inhibition induces cell cycle arrest and apoptosis in breast cancer via the P53-CDK1 axis and the BAX/Bcl2/caspase signaling cascade. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1585945

BibTeX
@article{Li2025,
  author = {Li, Pingchuan and Wei, Lineng and Li, Meng and Liu, Xiaoqiang and Yang, Huawei},
  title = {ESCO2 inhibition induces cell cycle arrest and apoptosis in breast cancer via the P53-CDK1 axis and the BAX/Bcl2/caspase signaling cascade},
  journal = {Frontiers in Oncology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fonc.2025.1585945}
}
Kostenlos starten →